CellOrigin Biotech

company

About

CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥100M
Industries
Biotechnology
Operating Status
Active

CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥100M
CellOrigin Biotech has raised a total of ¥100M in funding over 2 rounds. Their latest funding was raised on Mar 29, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 29, 2022 Series Unknown ¥100M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CellOrigin Biotech is funded by 1 investors. Jifeng Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Jifeng Ventures Series Unknown